blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1772462

EP1772462 - Steroid sulfamates, method for the production and use thereof [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.02.2014
Database last updated on 19.07.2024
Most recent event   Tooltip21.02.2014Application deemed to be withdrawnpublished on 26.03.2014  [2014/13]
Applicant(s)For all designated states
Sterix Limited
190 Bath Road
Slough, Berkshire SL1 3XE / GB
[2007/15]
Inventor(s)01 / Kasch, Helmut
Hans-Berger-Strasse 14
07745 Jena / DE
02 / Schumann, Winfried
Friedrich-Schelling-Strasse 2
07745 Jena / DE
03 / Römer, Johannes
Bautzner Landstrasse 29
01454 Grosserkmannsdorf / DE
04 / Steinbach, Jörg
Geschwister-Scholl-Strasse 14
01877 Bischofswerda / DE
 [2007/15]
Representative(s)Alcock, David, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2008/32]Alcock, David, et al
D Young & Co 120 Holborn
London EC1N 2DY / GB
Former [2008/01]Alcock, David, et al
D Young & Co 120 Holborn
London, EC1N 2DY / GB
Former [2007/15]Bradley, Adrian, et al
D Young & Co 120 Holborn London
EC1N 2DY / GB
Application number, filing date06016215.318.03.1998
[2007/15]
Priority number, dateDE199711248825.03.1997         Original published format: DE 19712488
[2007/15]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report 
No.:EP1772462
Date:11.04.2007
Language:DE
[2007/15]
Type: A3 Search report 
No.:EP1772462
Date:16.05.2012
Language:DE
[2012/20]
Search report(s)(Supplementary) European search report - dispatched on:EP18.04.2012
ClassificationIPC:C07J41/00, C07J53/00, C07J63/00, C07J71/00
[2012/20]
CPC:
C07J53/004 (EP,US); A61P15/12 (EP); A61P35/00 (EP);
A61P43/00 (EP); A61P5/30 (EP); C07J63/008 (EP,US);
C07J71/0031 (EP,US); Y02P20/55 (EP,US) (-)
Former IPC [2007/15]C07J41/00, A61K31/565, C07J71/00, C07J63/00, C07J53/00
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2007/15]
TitleGerman:Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben[2007/15]
English:Steroid sulfamates, method for the production and use thereof[2007/15]
French:Sulfamate de stéroide, procédé de production et utilisation de cette substance[2007/15]
Examination procedure04.08.2006Examination requested  [2007/15]
01.07.2013Despatch of a communication from the examining division (Time limit: M04)
01.10.2013Application deemed to be withdrawn, date of legal effect  [2014/13]
07.11.2013Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2014/13]
Parent application(s)   TooltipEP98924026.2  / EP0970104
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19980924026) is  09.07.2004
Fees paidRenewal fee
04.08.2006Renewal fee patent year 03
04.08.2006Renewal fee patent year 04
04.08.2006Renewal fee patent year 05
04.08.2006Renewal fee patent year 06
04.08.2006Renewal fee patent year 07
04.08.2006Renewal fee patent year 08
04.08.2006Renewal fee patent year 09
14.03.2007Renewal fee patent year 10
13.03.2008Renewal fee patent year 11
01.04.2008Renewal fee patent year 12
17.03.2010Renewal fee patent year 13
30.03.2011Renewal fee patent year 14
14.03.2012Renewal fee patent year 15
Penalty fee
Additional fee for renewal fee
31.03.201316   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO9305064  (IMPERIAL COLLEGE [GB]) [I] 1-9 * page 1, paragraph 1; examples 1,2,4, 7-8 * * page 5, lines 1-8 *;
 [X]WO9605216  (JENAPHARM GMBH [DE], et al) [X] 1,3,5-8 * page 5, paragraph 2 * * page 7, paragraph 4 * * page 11, line 36; claim 2 *;
 [ID]  - PUROHIT A ET AL, "Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate.", BIOCHEMISTRY 12 SEP 1995 LNKD- PUBMED:7547880, (19950912), vol. 34, no. 36, ISSN 0006-2960, pages 11508 - 11514, XP002673419 [ID] 1-9 * page 11508; compounds 4,5 * * page 11510, column 2, paragraph 4 *

DOI:   http://dx.doi.org/10.1021/bi00036a025
 [X]  - ROMER J ET AL, "Sulfamates of 3-hydroxy-estra-1-3-5(10)-triene derivatives", FZR, SN, DE, (199702), pages 182 - 187, XP002268510 [X] 1,3,5 * page 182, paragraph 1; compound 3 * * page 184, paragraph 2 *
 [XP]  - ROEMER J ET AL, "Examinations of the reaction of 16,17-O-sulfuryl-16-epiestriol-3- sulfamate with [18F]fluoride", FZR, SN, DE, (19971201), pages 185 - 188, XP002268509 [XP] 1,3,5 * page 185, paragraph 1; compounds 3a, 3b *
 [IP]  - ROEMER W ET AL, "SCAVESTROGEN SULFAMATES: CORRELATION BETWEEN ESTRONE SULFATASE INHIBITING AND ANTIOXIDANT EFFECTS", CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, OTTAWA, ONT, CA, (199802), vol. 76, no. 2, doi:10.1139/CJPP-76-2-99, pages 99 - 109, XP000852556 [IP] 1-9 * page 102; figure 1 * * page 103; table 1 *

DOI:   http://dx.doi.org/10.1139/cjpp-76-2-99
 [IP]  - PUROHIT A ET AL, "The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity", JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, ELSEVIER SCIENCE LTD., OXFORD, GB, vol. 64, no. 5-6, ISSN 0960-0760, (19980301), pages 269 - 275, (19980301), XP027368437 [IP] 1-9 * page 270; figure 1; compounds 1,2 * * page 271; table 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.